INTRODUCTION
Sickle cell disease is an inherited disorder of hemoglobin that has a worldwide impact on health and longevity.
Sickle cell disease, characterized by lifelong hemolytic anemia and a wide variety of painful and debilitating vaso-occlusive events, occurs in 70000 to 80000 Americans of African, Mediterranean, or Middle Eastern extraction¹. In the United States, the life expectancy for patients with sickle cell disease is shortened by about 30years², while in Africa, where comprehensive medical care is less available, death in early childhood is usual. In Nigeria the incidence is 1-2% of the population 3 . Medical advances in management of sickle cell disease has lead to significant increases in life expectancy of this group of patients. Improved public health, neonatal screening, parental and patient education, advances in red cell transfusion medicine, iron chelation therapy, penicillin prophylaxis for children, pneumococcal immunization, and hydroxyurea therapy have all likely contributed to this effect on longevity 4 .
ETIOPATHOGENESIS
The term sickle cell disorder refers to states in which the red cell undergoes sickling when it is deoxygenated. The sickle cell diseases are those disorders in which sickling produces prominent clinical manifestations. Included are sickle cell-hemoglobin C disease (hemoglobin SC disease), sickle cell-hemoglobin D disease (hemoglobin SD disease), sickle cell β-thalassemia, and sickle cell anemia. The latter term is reserved for the homozygous state for the sickle cell gene 5 . There are few diseases of man whose etiology can be traced to as basic a level as sickle cell disease. Sickle cell anemia is due to the substitution of thymine for adenine in the glutamic acid DNA codon (GAG to GTG), which results, in turn, in substitution at β6 of valine for glutamic acid 6 . Deoxygenation of HbS leads to a conformational change that exposes a hydrophobic patch on the surface of the β-globin chain. Binding of this site to a complementary hydrophobic site on a β-subunit of another hemoglobin tetramer triggers the formation of large polymers 7 .
This leads to the characteristic sickle or elongated shape of erythrocytes. Repeated or prolonged sickling causes progressive damage to the erythrocyte membrane which is of primary importance in the pathophysiology and presentation of SCD. Various factors are associated with sickling of red cells which include deoxygenation, vascular stasis, low temperature, acidosis, infections. When a cell sickles and unsickles repeatedly, the membrane is affected and the cell becomes irreversibly sickled; it remains so even when the oxygen pressure is increased. These are the sickled forms seen on air-dried films. An irreversibly sickled cell has a high hemoglobin concentration and a high calcium and low potassium content, and it may be ATPdepleted 8 .These cells appear to be derived directly from reticulocytes 9 but have a short intravascular life span, and the severity of the hemolytic process is directly related to the number of these cells in a patient's circulation 10 .
CLINICAL FEATURES
The newborn infant is protected by the high level of fetal hemoglobin in the red cells during the first 8 to 10 weeks of life. 
Genetic Counseling
Sickle cell trait (SCT) is not considered to be a health problem, but individuals who test positive should be informed about the implications for their health and family planning. There are two major circumstances in which adults will learn that they have SCT: 1. Parents of a child with SCT. When a newborn with SCT is identified through screening, at least one of the parents will have SCT. 2. Pregnant women. During prenatal care, women from racial groups with a high prevalence of the sickle cell gene are tested for the gene. SCT counseling has two components -education and decision-making-but the emphasis differs in the two cases above. For the first group, the focus is on education, that is, to enable individuals to make informed decisions, in their own interest, about future family planning. For the second group, the focus is on education and informed decisions, in their best interest, about the current pregnancy 15 . There is need for the use of broad spectrum antibiotics for SCD patients with fever, before culture results are available.
Psychosocial management

Transient Red Cell Aplasia
Because the life span of red blood cells is greatly shortened in sickle cell disease (SCD), temporary suppression of erythropoiesis can result in severe anemia. Transient red cell aplasia (TRCA) typically is preceded by or associated with a febrile illness. Between 70 and 100 percent of episodes of TRCA are due to infection by human parvovirus B19, also the cause of erythema infectiosum ("fifth disease") 21 . Aplasia is the result of direct cytotoxicity of the parvovirus to erythroid precursors, although other progenitors may be affected in some conditions No experimental trials have been reported regarding the management of TRCA. Although many patients recover spontaneously, red cell transfusions should be considered for those who become symptomatic 15 . 
Stroke and CNS Disease
Acute Chest Syndrome (ACS)
ACS is an acute illness characterized by fever and respiratory symptoms, accompanied by a new pulmonary infiltrate on a chest x ray. Because the appearance of radiographic changes may be delayed 24 , the diagnosis may not be recognized immediately. A major risk factor for the development of ACS is the hemoglobin genotype: the highest incidence is seen in Hb SS genotype (12.8 events/100 personyears) and the lowest in Hb-S +β-thalassemia genotype (3.9 events/100 person years) 25 . ACS is the second most common cause of hospitalization in sickle cell patients and the most common complication of surgery and anesthesia 26 .
Oxygen.
Assessment of blood oxygenation requires determination of baseline arterial blood gases (ABG), and estimation of the alveolar arterial (A-a) oxygen gradient and the PaO2/FiO2 ratio. Oxygen should be administered to moderately hypoxemic patients (PaO2 = 70-80 mm Hg, O2 saturation = 92-95 percent) nasally at a rate of 2 liters per min. Chronically hypoxemic patients in whom the admission PaO2 is no lower than in their steady state may still benefit from oxygen because they may not tolerate additional hypoxemia due to ACS. Control of chest pain and incentive spirometry can prevent hypoventilation in most patients 27 41 .Erythropoietin levels in SCD patients fall still further as renal function worsens and these patients may require substantially higher doses of erythropoietin than are required for patients with other forms of ESRD 42 . If erythropoietin is ineffective, transfusions can be given; they must be done carefully, however, to avoid volume overload. As with all patients who develop ESRD, SCD patients can be treated with both hemodiaylsis and peritoneal dialysis, and they can undergo renal transplantation.
Priapism
Beginning in early boyhood, males need to know that priapism is one aspect of SCD and that this is not an event that should embarrass them. Boys and young men, as well as their families, need to know that they should be prepared to seek medical attention as soon as an episode begins and that if untreated, priapism can result in impotence in the future. The males should know that a full bladder can trigger priapism, and they therefore need to urinate regularly. They also should avoid prolonged sexual activity, which can trigger an episode. If they have had more than one episode, medications can be prescribed that may prevent recurrences. The goal of therapy is to ease pain, make the erection go away, and preserve future erectile function. If treatment is given within 4 to 6 hours, the erection can generally be reduced with medication and conservative therapy 15 . Patients should be advised to drink extra fluids, use oral analgesics, and attempt to urinate as soon as priapism begins.
For episodes lasting more than two hours, patients should go to the emergency room to receive intravenous hydration and parenteral analgesia. According to one protocol 43 , if detumescence does not occur in 1 hour after the patient has arrived in the emergency room, penile aspiration is initiated (procedure should be performed within 4 to 6 hours from onset of priapism). The patient receives conscious sedation and local anesthesia; blood is then aspirated from the corpus cavernosum with a 23-gauge needle followed by irrigation of the corpora with a 1:1,000,000 solution of epinephrine in saline. The concomitant use of automated red cell exchange transfusions to reduce the sickle hemoglobin (Hb S) level to less than 30 percent can also be considered, especially if early intervention with irrigation fails 44 . If there is recurrence despite aspiration and local instillation of vaso-active drugs, shunting may be considered. In this procedure, known as the Winter procedure, a shunt is created between the glans penis and the distal corpora cavernosa with a Tru-cut biopsy needle; this allows blood from the distended corpora cavernosa to drain into the uninvolved corpus spongiosa 45 .Additional medications used for reversal of priapism include -agonists.If impotence persists for 12 months, the patient may wish to consider implantation of a semi rigid penile prosthesis 46 . Some physicians prescribe 30 mg of oral pseudoephedrine at night as an attempt to prevent further episodes in those who have had priapism and have required aspiration and irrigation 43 .Injections of leuprolide, a gonadotropin releasing hormone analogue that suppresses the hypothalamic-testicular axis and the production of testosterone, also has also been used with some degree of success as prophylaxis against further episodes 47 . A small (11 patients) double-blind, placebo-controlled crossover study found that oral stilbestrol in doses of 5 mg daily for 3 to 4 days could abort episodes of priapism and that much smaller doses could prevent recurrence 48 .Although hydroxyurea may potentially be of benefit 49 , clinical studies to determine its efficacy in preventing priapism have not been performed.
Musculoskeletal Abnormalities
Musculoskeletal manifestations of sickle cell disease (SCD) are common and may lead to severe morbidity. Bone and joint involvement result from three main causes: 1) bone marrow hyperplasia, which causes distortion and growth disturbance, particularly in the skull, vertebrae, and long bones; 2) vaso-occlusive events that lead to infarction of metaphyseal and diaphyseal bone and to osteonecrosis of juxta-articular bone; and 3) hematogenous bacterial infection that results in osteomyelitis and septic arthritis. Conservative management by analgesia, rehydration, transfusions and appropriate antibiotics are recommended for uncomplicated cases. Surgical intervention for those with advanced disease and for whom all other conservative measures have failed is recommended 15 . These include, core decompression and osteotomy for osteonecrosis, hip replacement, prosthesis and surgical drainage for septic arthritis and osteomyelitis 15 .
Leg Ulcers
Between 10 and 20 percent of patients with sickle cell disease (SCD) due to a homozygous hemoglobin S (Hb S) genotype (SCD-SS) develop painful, disfiguring, and indolent leg ulcers. The ulcers usually appear between ages 10 and 50 years and are seen more frequently in males than in females 15 . Studies to prove the efficacy of treatment of leg ulcers are difficult to perform. One reason is that healing depends on blood circulation, and the cumulative time of bed rest and leg elevation is not easily monitored. In addition, the variable extent of wound debridement is difficult to quantify, and a short period of dependency could erase any gains made in the previous period. Ankle ulcers are painful, and the patient should be given moderately potent analgesics such as oxycodone. Bed rest and elevation of the leg to reduce edema are useful, though not always practical. Wet-to-dry dressings, even if applied only 2 or 3 times a day, can provide gentle debridement; cooperation of patients increases when they are permitted to dampen the dressing slightly before removal, since it is a painful process. Oral zinc sulfate (200 mg 3 times a day) probably does no harm if it does not cause nausea, and may be worth using 15 . The ulcer size should be measured at every clinic visit; seeing the dimensions shrink can provide encouragement to the patient. Some ulcers will not heal. Rigorous studies have not been done to assess the utility of transfusions for treating leg ulcers, but the ulcers seem to correlate with degree of anemia, which suggests transfusions may help. They should be considered for recalcitrant or recurrent skin ulcers if conservative therapy fails. If transfusions are used, they probably should be continued for 3 to 6 months, and a hemoglobin concentration above 10 g/dL with Hb S levels less than 50 percent can be achieved 15 . More complete bed rest, systemic antibiotics, transfusions, and skin grafts sometimes help. If split thickness or pinch grafts are to be used, preoperative preparation of the ulcer bed is probably quite important.
Quantitative bacterial cultures of biopsies of the bed and margin are advocated by some 50 but not all 51 surgeons as a guide to the time for surgery. Intravenous arginine butyrate infusions have been reported to cause rapid healing of ankle ulcers 52 .
Pregnancy
Prenatal care for women with SCD should be managed by a multidisciplinary team that includes an obstetrician, nutritionist, primary care physician, and hematologist. The team must decide who will be responsible for each aspect of the patient's care. Close monitoring, combined with prompt diagnosis and aggressive treatment of complications during the prenatal and neonatal period by a multidisciplinary team, will contribute to better outcomes 15 . The clinical problems of SCD, such as new onset seizures, hepatopathy, acute anemia, and painful episodes should be evaluated and managed for pregnant women in the same fashion as for women who are not pregnant. Women who have had previous pregnancy losses or who have multiple gestations may benefit from the early use of transfusions to maintain a hemoglobin level above 9 g/dL 15 .
Anaesthesia and Surgery
• Make sure the operating and anesthesia teams are aware of the diagnosis of a sickle cell syndrome and the need for special attention.
• In patients with SCD-SS, and SCD-SC, simple transfusion to a hemoglobin of 10 g/dLshould be performed before all but the lowest-risk procedures. 
Transfusion
Used correctly, transfusion can prevent organ damage and save the lives of sickle cell disease (SCD) patients. Used unwisely, transfusion therapy can result in serious complications. Once a decision is made to transfuse, the type of red cells to be given is specified and goals are set for the final post transfusion hematocrit and percent sickle hemoglobin (Hb S) desired.In general, phenotypically matched, sickle negative, leukodepleted packed cells are the blood product of choice, and a post transfusion hematocrit of 36 percent or less is recommended, since a higher value theoretically causes hyper viscosity, which is dangerous to sickle cell patients 15 . Transfusions are used to raise the oxygen carrying capacity of blood and decrease the proportion of sickle red cells. Clinically, they will improve micro vascular perfusion of tissues.
Induction of Fetal Hemoglobin
Enhanced concentrations of hemoglobin F (Hb F) can inhibit sickle hemoglobin (Hb S) polymerization and red cell sickling and improve the clinical course of sickle cell disease (SCD). In a cooperative study of the natural history of patients with sickle cell anemia in the United States, the frequency of pain episodes correlated inversely with the Hb F concentration.
Based on these epidemiologic studies and understanding the biophysics of Hb S polymerization, a search was launched for pharmacologic agents that could reverse the switch from γ-to β-globin chain synthesis in erythroid precursors. The first "hemoglobin switching" agent was the nucleoside analog 5-azacytidine 53 
